lisamisena

Lisamisena is a brand name for semaglutide, a medication used for the treatment of type 2 diabetes and chronic weight management. Semaglutide belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. It works by mimicking the action of the natural hormone GLP-1, which helps regulate blood sugar levels and promote feelings of fullness.

In type 2 diabetes, Lisamisena helps to lower blood glucose by increasing insulin secretion, decreasing glucagon secretion, and slowing down gastric emptying. This leads to improved glycemic control. For chronic weight management, Lisamisena is prescribed to individuals who are overweight or obese, or who are overweight with weight-related comorbidities. It aids in weight loss by reducing appetite and increasing satiety.

Lisamisena is typically administered as a once-weekly subcutaneous injection. The dosage and frequency are determined by a healthcare professional based on the patient's individual needs and response to treatment. Common side effects may include nausea, vomiting, diarrhea, constipation, and abdominal pain. It is important to discuss any potential risks and benefits with a doctor before starting Lisamisena. The medication is not intended for individuals with type 1 diabetes or diabetic ketoacidosis.